CN109096082A - A method of synthesis alpha-iodine is for cyclopentene ketone compounds - Google Patents

A method of synthesis alpha-iodine is for cyclopentene ketone compounds Download PDF

Info

Publication number
CN109096082A
CN109096082A CN201811127426.8A CN201811127426A CN109096082A CN 109096082 A CN109096082 A CN 109096082A CN 201811127426 A CN201811127426 A CN 201811127426A CN 109096082 A CN109096082 A CN 109096082A
Authority
CN
China
Prior art keywords
iodine
alpha
ketone compounds
cyclopentene ketone
synthesis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201811127426.8A
Other languages
Chinese (zh)
Other versions
CN109096082B (en
Inventor
饶卫东
周劭诺
周媛媛
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanjing Forestry University
Original Assignee
Nanjing Forestry University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanjing Forestry University filed Critical Nanjing Forestry University
Priority to CN201811127426.8A priority Critical patent/CN109096082B/en
Publication of CN109096082A publication Critical patent/CN109096082A/en
Application granted granted Critical
Publication of CN109096082B publication Critical patent/CN109096082B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/687Unsaturated compounds containing a keto groups being part of a ring containing halogen
    • C07C49/697Unsaturated compounds containing a keto groups being part of a ring containing halogen containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/21Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/02Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
    • C07C69/12Acetic acid esters
    • C07C69/14Acetic acid esters of monohydroxylic compounds
    • C07C69/145Acetic acid esters of monohydroxylic compounds of unsaturated alcohols
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/06Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/10Systems containing only non-condensed rings with a five-membered ring the ring being unsaturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention discloses a kind of synthesis alpha-iodines for the method for cyclopentene ketone compounds, it includes, it is golden (I) that eneyne ester, (acetonitrile) [(2- biphenyl) di-t-butyl phosphine] hexafluoro-antimonic acid are added in t-butyl methyl ether solution, confirms that raw material total overall reaction is complete by TLC after stirring 1 hour and adds N- N-iodosuccinimide.It is provided by the present invention a kind of alpha-iodine to be synthesized for the method for cyclopentene ketone compounds by non-annularity eneyne ester type compound.Entire reaction carries out at normal temperatures and pressures, has many advantages, such as that easy to operate, mild condition, substrate functional group good compatibility, product yield high, catalyst and product are easily separated.Alpha-iodine obtained is researched and developed for cyclopentene ketone compounds reactivity with higher, a kind of important organic intermediate is can be used as and is applied to the fields such as the synthesis of medicine, pesticide and natural products.

Description

A method of synthesis alpha-iodine is for cyclopentene ketone compounds
Technical field
The invention belongs to chemosynthesis technical fields, and in particular to a method of synthesis alpha-iodine is for cyclopentenone.
Background technique
Halo carbonyl compounds are the important intermediates in the fields such as organic synthesis, biomedicine and pharmacy.Wherein most often What is seen is α-halogenatedketone, and most of with potential bioactivity.For example, George Sakoulas etc. reports one kind newly Type natural products Merochlorin A has the activity of external anti-multiple medicine gram-positive bacteria, and has and other antibacterial agents With entirely different skeleton structure.The introducing of halogen atom will be for the functional molecular including natural products, drug etc. Further chemical conversion provides some novel methods.
However known alpha-iodine is limited only to non-annularity alpha-iodine for ketone for the synthetic method substrate of ketone, and by non-annularity Precursor compound efficiently synthesizes alpha-iodine generation cyclic annular ketenes and then has not been reported.The present invention provide a kind of mild condition, it is easy to operate, produce Rate is higher, substrate applicability preferably synthesizes alpha-iodine for the preparation method of cyclopentenone, will be alpha-iodine for ketone and complicated natural production The synthesis of object provides new approach.
Summary of the invention
Regarding the issue above, the present invention provides a kind ofSubstrate functional group good compatibility, product yield highConjunction At alpha-iodine for the method for cyclopentenone.
In order to solve the above technical problems, the present invention provides the following technical scheme that alpha-iodine of the invention is for cyclopentene ketone Compound, general structure of the alpha-iodine for cyclopentene ketone compounds:
In formula, R1、R2For group independent, and carbon number is 1~16;
R1For substituent group, including any one in phenyl, naphthalene, halogenophenyl, naphthenic base;
R2For substituent group, including methyl, chain-like alkyl, naphthenic base, carbonyl, ester group, benzenesulfonyl, phenyl, nitrogen-containing hetero One of cyclic group or several combinations.
Synthesis alpha-iodine of the present invention includes the following steps: first to sequentially add for the method for cyclopentene ketone compounds Methyl tertiary butyl ether(MTBE), eneyne ester, (acetonitrile) [(2- biphenyl) di-t-butyl phosphine] hexafluoro-antimonic acid are golden (I), and stirring passes through after 1 hour TLC confirms that raw material total overall reaction is complete and adds N- N-iodosuccinimide, stirs 2 hours under normal temperature and pressure, then by reaction solution Concentrated by rotary evaporation, and target product alpha-iodine is obtained for cyclopentenone by silica gel column chromatography.
Further, the eneyne ester includes eneyne ester type compound as shown below,
In formula, R1、R2With above-mentioned R1、R2It is corresponding consistent.
Further, concentration of the eneyne ester in methyl tertiary butyl ether(MTBE) is 0.1mol/L.
Further, the eneyne ester and (acetonitrile) [(2- biphenyl) di-t-butyl phosphine] hexafluoro-antimonic acid golden (I) rubs You are than being 1: 0.02.
Further, the molar ratio of the eneyne ester and N- N-iodosuccinimide is 1: 2.
Further, the revolving speed of the revolving be 150~300rpm, temperature be 35~45 DEG C, vacuum degree be 0.05~ 0.09Mpa, processing time are 5~15min.
Further, the silica gel column chromatography, using 200~300 mesh column chromatography silica gels, eluant, eluent is ethyl acetate : petroleum ether=1~30: 100.
It is carried out at normal temperatures and pressures the utility model has the advantages that the present invention entirely reacts, there is easy to operate, mild condition, substrate official The advantages that good compatibility, product yield high, easily separated catalyst and product can be rolled into a ball.Alpha-iodine obtained is researched and developed for cyclopentene ketone Object reactivity with higher is closed, a kind of important organic intermediate is can be used as and is applied to medicine, pesticide and naturally produces The fields such as the synthesis of object.
Detailed description of the invention
In order to illustrate the technical solution of the embodiments of the present invention more clearly, required use in being described below to embodiment Attached drawing be briefly described, it should be apparent that, drawings in the following description are only some embodiments of the invention, for this For the those of ordinary skill of field, without any creative labor, it can also be obtained according to these attached drawings other Attached drawing.Wherein:
Fig. 1 is the nucleus magnetic hydrogen spectrum figure of compound 2a;
Fig. 2 is the nuclear-magnetism carbon spectrogram of compound 2a, and Fig. 1 and Fig. 2 show that compound 2a structure is correct;
Fig. 3 is the nucleus magnetic hydrogen spectrum figure of compound 2b;
Fig. 4 is the nuclear-magnetism carbon spectrogram of compound 2b, and Fig. 3 and Fig. 4 show that compound 2b structure is correct;
Fig. 5 is the nucleus magnetic hydrogen spectrum figure of compound 2c;
Fig. 6 is the nuclear-magnetism carbon spectrogram of compound 2c, and Fig. 5 and Fig. 6 show that compound 2c structure is correct;
Fig. 7 is the nucleus magnetic hydrogen spectrum figure of compound 2d;
Fig. 8 is the nuclear-magnetism carbon spectrogram of compound 2d, and Fig. 7 and Fig. 8 show that compound 2d structure is correct;
Fig. 9 is the nucleus magnetic hydrogen spectrum figure of compound 2e;
Figure 10 is the nuclear-magnetism carbon spectrogram of compound 2e, and Fig. 9 and Figure 10 show that compound 2e structure is correct;
Figure 11 is the nucleus magnetic hydrogen spectrum figure of compound 2f;
Figure 12 is the nuclear-magnetism carbon spectrogram of compound 2f, and Figure 11 and Figure 12 show that compound 2f structure is correct;
Figure 13 is the nucleus magnetic hydrogen spectrum figure of compound 2g;
Figure 14 is the nuclear-magnetism carbon spectrogram of compound 2g, and Figure 13 and Figure 14 show that compound 2g structure is correct;
Figure 15 is the nucleus magnetic hydrogen spectrum figure of compound 2h;
Figure 16 is the nuclear-magnetism carbon spectrogram of compound 2h, and Figure 15 and Figure 16 show that compound 2h structure is correct.
Specific embodiment
In order to make the foregoing objectives, features and advantages of the present invention clearer and more comprehensible, right combined with specific embodiments below A specific embodiment of the invention is described in detail.
In the following description, numerous specific details are set forth in order to facilitate a full understanding of the present invention, but the present invention can be with Implemented using other than the one described here other way, those skilled in the art can be without prejudice to intension of the present invention In the case of do similar popularization, therefore the present invention is not limited by the specific embodiments disclosed below.
Embodiment 1
25mL round-bottomed flask is taken, 5mL methyl tertiary butyl ether(MTBE), eneyne 1a (107.2mg, 0.5mmol), (acetonitrile) are sequentially added [(2- biphenyl) di-t-butyl phosphine] hexafluoro-antimonic acid gold (I) (7.8mg, 0.01mmol) confirms raw material by TLC after stirring 1 hour Total overall reaction is complete to add N- N-iodosuccinimide (225mg, 1mmol).Under normal temperature and pressure, with 500rpm stirring 2 hours.So It is rotated afterwards using Heidolph Rotary Evaporators, revolving speed 150rpm, temperature is 42 DEG C, vacuum degree 0.06Mpa, when processing Between be 10min.Again by 200~300 mesh silica gel column chromatographies, eluant, eluent is ethyl acetate: petroleum ether=3: 100, it is isolated (136.7mg, 0.46mmol, yield 93% also can reflect target product 2a from nuclear magnetic spectrum shape, signal, noise etc. Product purity is high out).
1H NMR (600MHz, CDCl3): δ 7.62-7.60 (m, 2H), 7.51-7.44 (m, 3H), 6.60 (t, 1H, J= 1.7Hz), 3.86 (dd, 1H, J=19.1,1.5Hz), 3.47 (dd, 1H, J=19.1,2.0Hz), 2.02 (s, 3H);13C NMR (150MHz, CDCl3): δ 204.8,167.2,133.1,131.9,129.1,127.0,121.9,51.2,37.7,30.6.
Embodiment 2
25mL round-bottomed flask is taken, 5mL methyl tertiary butyl ether(MTBE), eneyne 1b (151mg, 0.5mmol), (acetonitrile) are sequentially added [(2- biphenyl) di-t-butyl phosphine] hexafluoro-antimonic acid gold (I) (7.8mg, 0.01mmol) confirms raw material by TLC after stirring 1 hour Total overall reaction is complete to add N- N-iodosuccinimide (225mg, 1mmol).Under normal temperature and pressure, with 500rpm stirring 3 hours.So It is rotated afterwards using Heidolph Rotary Evaporators, revolving speed 150rpm, temperature is 42 DEG C, vacuum degree 0.06Mpa, when processing Between be 10min.Again by 200~300 mesh silica gel column chromatographies, eluant, eluent is ethyl acetate: petroleum ether=5:100, isolated (176.7mg, 0.46mmol, yield 92% also can reflect target product 2b from nuclear magnetic spectrum shape, signal, noise etc. Product purity is high out).
1H NMR (600MHz, CDCl3): δ 7.60 (d, 2H, J=7.3Hz), 7.50-7.43 (m, 3H), 6.59 (s, 1H), 4.08 (t, 2H, J=6.3Hz), 3.69 (d, 1H, J=19.2Hz), 3.46 (dd, 1H, J=19.2,1.8Hz), 2.20-2.15 (m, 1H), 2.01 (s, 3H), 1.94-1.88 (m, 1H), 1.74-1.63 (m, 2H)
13C NMR (150MHz, CDCl3): δ 204.2,171.0,167.7,132.9,132.0,129.2,127.0, 122.5,63.6,48.3,44.6,37.9,27.5,21.0.
Embodiment 3
25mL round-bottomed flask is taken, 5mL methyl tertiary butyl ether(MTBE), eneyne 1c (243.8mg, 0.5mmol), (acetonitrile) are sequentially added [(2- biphenyl) di-t-butyl phosphine] hexafluoro-antimonic acid gold (I) (7.8mg, 0.01mmol) confirms raw material by TLC after stirring 1 hour Total overall reaction is complete to add N- N-iodosuccinimide (225mg, 1mmol).Under normal temperature and pressure, with 500rpm stirring 2 hours.So It is rotated afterwards using Heidolph Rotary Evaporators, revolving speed 150rpm, temperature is 42 DEG C, vacuum degree 0.06Mpa, when processing Between be 10min.Again by 200~300 mesh silica gel column chromatographies, eluant, eluent is ethyl acetate: petroleum ether=20: 100, it is isolated (245.7mg, 0.43mmol, yield 86% also can reflect target product 2c from nuclear magnetic spectrum shape, signal, noise etc. Product purity is high out).
1H NMR (600MHz, CDCl3): δ 7.57-7.56 (m, 2H), 7.50-7.49 (m, 1H), 7.47-7.43 (m, 4H), 7.30-7.28 (m, 3H), 7.23 (d, 2H, J=8.0Hz), 7.05-7.03 (m, 2H), 6.55 (t, 1H, J=1.6Hz), 3.63- 3.56 (m, 3H), 3.34 (dd, 1H, J=19.1,1.9Hz), 2.41 (s, 3H), 2.16 (t, 1H, J=10.3Hz), 1.75- 1.69 (m, 2H), 1.58-1.54 (m, 1H)
13C NMR (150MHz, CDCl3): δ 204.1,167.7,143.5,139.0,134.9,132.9,131.9, 129.4,129.1,129.1,128.7,128.0,127.7,127.0,122.4,49.9,48.5,44.7,38.2,27.1, 21.6.
Embodiment 4
25mL round-bottomed flask is taken, 5mL methyl tertiary butyl ether(MTBE), eneyne 1d (141.2mg, 0.5mmol), (acetonitrile) are sequentially added [(2- biphenyl) di-t-butyl phosphine] hexafluoro-antimonic acid gold (I) (7.8mg, 0.01mmol) confirms raw material by TLC after stirring 1 hour Total overall reaction is complete to add N- N-iodosuccinimide (225mg, 1mmol).Under normal temperature and pressure, with 500rpm stirring 2 hours.So It is rotated afterwards using Heidolph Rotary Evaporators, revolving speed 150rpm, temperature is 42 DEG C, vacuum degree 0.06Mpa, when processing Between be 10min.Again by 200~300 mesh silica gel column chromatographies, eluant, eluent is ethyl acetate: petroleum ether=3: 100, it is isolated (162.9mg, 0.45mmol, yield 89% also can reflect target product 2d from nuclear magnetic spectrum shape, signal, noise etc. Product purity is high out).
1H NMR (600MHz, CDCl3): δ 7.64-7.62 (m, 2H), 7.51-7.44 (m, 3H), 6.63 (t, 1H, J= 1.7Hz), 3.55 (qd, 2H, J=19.4,1.9Hz), 2.36 (d, 1H, J=12.8Hz), 2.05-2.00 (m, 1H), 1.89 (d, 1H, J=13.6Hz), 1.65 (dd, 3H, J=10.4,1.4Hz), 1.37-1.11 (m, 4H), 0.89 (qd, 1H, J=11.9, 2.9Hz).
13C NMR (150MHz, CDCl3): δ 204.9,168.0,133.2,131.8,129.1,127.0,123.4,54.2, 46.4,45.0,31.7,27.2,26.6,26.2,25.6.
Embodiment 5
25mL round-bottomed flask is taken, 5mL methyl tertiary butyl ether(MTBE), eneyne 1e (124.4mg, 0.5mmol), (acetonitrile) are sequentially added [(2- biphenyl) di-t-butyl phosphine] hexafluoro-antimonic acid gold (I) (7.8mg, 0.01mmol) confirms raw material by TLC after stirring 1 hour Total overall reaction is complete to add N- N-iodosuccinimide (225mg, 1mmol).Under normal temperature and pressure, with 500rpm stirring 2 hours.So It is rotated afterwards using Heidolph Rotary Evaporators, revolving speed 150rpm, temperature is 42 DEG C, vacuum degree 0.06Mpa, when processing Between be 10min.Again by 200~300 mesh silica gel column chromatographies, eluant, eluent is ethyl acetate: petroleum ether=3: 100, it is isolated (138.1mg, 0.42mmol, yield 83% also can reflect target product 2e from nuclear magnetic spectrum shape, signal, noise etc. Product purity is high out).
1H NMR (600MHz, CDCl3): δ 7.54-7.52 (m, 2H), 7.43-7.42 (m, 2H), 6.54 (t, 1H, J= 1.7Hz), 3.79 (dd, 1H, J=19.1,1.4Hz), 3.41 (dd, 1H, J=19.1,2.0Hz), 1.99 (s, 3H)13C NMR (150MHz, CDCl3): δ 204.5,165.6,138.0,131.6,129.4,128.2,122.3,51.1,37.3,30.5.
Embodiment 6
25mL round-bottomed flask is taken, 5mL methyl tertiary butyl ether(MTBE), eneyne 1f (132.2mg, 0.5mmol), (acetonitrile) are sequentially added [(2- biphenyl) di-t-butyl phosphine] hexafluoro-antimonic acid gold (I) (7.8mg, 0.01mmol) confirms raw material by TLC after stirring 1 hour Total overall reaction is complete to add N- N-iodosuccinimide (225mg, 1mmol).Under normal temperature and pressure, with 500rpm stirring 2 hours.So It is rotated afterwards using Heidolph Rotary Evaporators, revolving speed 150rpm, temperature is 42 DEG C, vacuum degree 0.06Mpa, when processing Between be 10min.Again by 200~300 mesh silica gel column chromatographies, eluant, eluent is ethyl acetate: petroleum ether=5: 100, it is isolated (156.7mg, 0.45mmol, yield 90% also can reflect target product 2f from nuclear magnetic spectrum shape, signal, noise etc. Product purity is high out).
1H NMR (600MHz, CDCl3): δ 8.02 (s, 1H), 7.91-7.86 (m, 3H), 7.71 (dd, 1H, J=8.6, 1.8Hz), 7.60-7.54 (m, 2H), 6.69 (t, 1H, J=1.7Hz), 3.99 (dd, 1H, J=18.9,1.4Hz), 3.57 (dd, 1H, J=18.9,2.0Hz), 2.05 (s, 3H)
13C NMR (150MHz, CDCl3): δ 204.8,166.9,134.8,132.9,130.4,129.0,128.9, 128.2,127.9,127.3,127.1,123.8,122.2,51.2,37.8,30.7.
Embodiment 7
25mL round-bottomed flask is taken, 5mL methyl tertiary butyl ether(MTBE), eneyne 1g (128.2mg, 0.5mmol), (acetonitrile) are sequentially added [(2- biphenyl) di-t-butyl phosphine] hexafluoro-antimonic acid gold (I) (7.8mg, 0.01mmol) confirms raw material by TLC after stirring 1 hour Total overall reaction is complete to add N- N-iodosuccinimide (225mg, 1mmol).Under normal temperature and pressure, with 500rpm stirring 2 hours.So It is rotated afterwards using Heidolph Rotary Evaporators, revolving speed 150rpm, temperature is 42 DEG C, vacuum degree 0.06Mpa, when processing Between be 10min.Again by 200~300 mesh silica gel column chromatographies, eluant, eluent is ethyl acetate: petroleum ether=5: 100, it is isolated (98.7mg, 0.29mmol, yield 58% also can reflect target product 2g from nuclear magnetic spectrum shape, signal, noise etc. Product purity is high out).
1H NMR (600MHz, C6D6): δ 7.18-7.15 (m, 2H), 7.09 (t, 1H, J=7.4Hz), 6.97 (d, 2H, J= 7.2Hz), 5.65 (s, 1H), 2.79 (d, 1H, J=19.4Hz), 2.26 (t, 2H, J=7.5Hz), 2.13 (dd, 1H, J= 20.3,0.8Hz), 1.66 (s, 3H), 1.62-1.59 (m, 2H), 1.38-1.33 (m, 2H);
13C NMR (150MHz, C6D6): δ 203.3,173.6,141.2,128.4 (d, 2C, J=10.3Hz), 126.1, 123.8,53.0,38.0,35.1,31.8,29.8,27.8.
Embodiment 8
25mL round-bottomed flask is taken, 5mL methyl tertiary butyl ether(MTBE), eneyne 1h (127.2mg, 0.5mmol), (acetonitrile) are sequentially added [(2- biphenyl) di-t-butyl phosphine] hexafluoro-antimonic acid gold (I) (7.8mg, 0.01mmol) confirms raw material by TLC after stirring 1 hour Total overall reaction is complete to add N- N-iodosuccinimide (225mg, 1mmol).Under normal temperature and pressure, with 500rpm stirring 2 hours.So It is rotated afterwards using Heidolph Rotary Evaporators, revolving speed 150rpm, temperature is 42 DEG C, vacuum degree 0.06Mpa, when processing Between be 10min.Again by 200~300 mesh silica gel column chromatographies, eluant, eluent is ethyl acetate: petroleum ether=3: 100, it is isolated (93.0mg, 0.28mmol, yield 55% also can reflect target product 2h from nuclear magnetic spectrum shape, signal, noise etc. Product purity is high out).
1H NMR (600MHz, CDCl3): δ 7.61-7.60 (m, 2H), 7.48-7.46 (m, 3H), 6.50 (s, 1H), 4.01 (dd, 1H, J=9.4,6.5Hz), 2.61-2.57 (m, 1H), 2.38-2.33 (m, 1H), 2.14-2.09 (m, 1H), 1.62- 1.51 (m, 3H), 1.32-1.16 (m, 2H)
13C NMR (150MHz, CDCl3): δ 203.9,173.8,132.7,131.3,129.1,127.3,121.8,54.0, 48.1,36.0,30.7,23.3,20.5.
It can be seen that one kind provided by the present invention synthesizes alpha-iodine for cyclopentene ketone by non-annularity eneyne ester type compound The method of compound.Entire reaction carries out at normal temperatures and pressures, has easy to operate, mild condition, substrate functional group compatibility Well, the advantages that product yield high, easily separated catalyst and product.Research and develop alpha-iodine obtained for cyclopentene ketone compounds have compared with High reactivity can be used as a kind of important organic intermediate and be applied to medicine, pesticide and synthesis of natural products etc. Field.
It should be noted that the above examples are only used to illustrate the technical scheme of the present invention and are not limiting, although referring to preferable Embodiment describes the invention in detail, those skilled in the art should understand that, it can be to technology of the invention Scheme is modified or replaced equivalently, and without departing from the spirit and scope of the technical solution of the present invention, should all be covered in this hair In bright scope of the claims.

Claims (8)

1. alpha-iodine is for cyclopentene ketone compounds, it is characterised in that: the alpha-iodine is logical for the structure of cyclopentene ketone compounds Formula:
In formula, R1、R2For group independent, and carbon number is 1~16;
R1For substituent group, including any one in phenyl, naphthalene, halogenophenyl, naphthenic base;
R2For substituent group, including methyl, chain-like alkyl, naphthenic base, carbonyl, ester group, benzenesulfonyl, phenyl, nitrogen-containing heterocycle group One of or several combinations.
2. synthesis alpha-iodine described in claim 1 is for the method for cyclopentene ketone compounds, it is characterised in that include the following steps: It is golden (I) first to sequentially add methyl tertiary butyl ether(MTBE), eneyne ester, (acetonitrile) [(2- biphenyl) di-t-butyl phosphine] hexafluoro-antimonic acid, stirring 1 is small When after by TLC confirmation, raw material total overall reaction is complete adds N- N-iodosuccinimide, stir 2 hours under normal temperature and pressure, then Target product alpha-iodine is obtained for cyclopentenone by reaction solution concentrated by rotary evaporation, and by silica gel column chromatography.
3. method of the synthesis alpha-iodine for cyclopentene ketone compounds as claimed in claim 1 or 2, it is characterised in that: described Eneyne ester includes eneyne ester type compound as shown below,
In formula, R1、R2With above-mentioned R1、R2It is corresponding consistent.
4. method of the synthesis alpha-iodine for cyclopentene ketone compounds as claimed in claim 1 or 2, it is characterised in that: described Concentration of the eneyne ester in methyl tertiary butyl ether(MTBE) is 0.1mol/L.
5. method of the synthesis alpha-iodine for cyclopentene ketone compounds as claimed in claim 1 or 2, it is characterised in that: described The molar ratio of eneyne ester and (acetonitrile) [(2- biphenyl) di-t-butyl phosphine] hexafluoro-antimonic acid golden (I) is 1: 0.02.
6. method of the synthesis alpha-iodine for cyclopentene ketone compounds as claimed in claim 1 or 2, it is characterised in that: described The molar ratio of eneyne ester and N- N-iodosuccinimide is 1: 2.
7. method of the synthesis alpha-iodine for cyclopentene ketone compounds as claimed in claim 2, it is characterised in that: the revolving Revolving speed be 150~300rpm, temperature be 35~45 DEG C, vacuum degree be 0.05~0.09Mpa, the processing time be 5~15min.
8. method of the synthesis alpha-iodine for cyclopentene ketone compounds as claimed in claim 2, it is characterised in that: the silica gel Column chromatography, using 200~300 mesh column chromatography silica gels, eluant, eluent is ethyl acetate: petroleum ether=1~30: 100.
CN201811127426.8A 2018-09-21 2018-09-21 Method for synthesizing alpha-iodo-cyclopentenone compound Active CN109096082B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201811127426.8A CN109096082B (en) 2018-09-21 2018-09-21 Method for synthesizing alpha-iodo-cyclopentenone compound

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201811127426.8A CN109096082B (en) 2018-09-21 2018-09-21 Method for synthesizing alpha-iodo-cyclopentenone compound

Publications (2)

Publication Number Publication Date
CN109096082A true CN109096082A (en) 2018-12-28
CN109096082B CN109096082B (en) 2021-04-27

Family

ID=64867110

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201811127426.8A Active CN109096082B (en) 2018-09-21 2018-09-21 Method for synthesizing alpha-iodo-cyclopentenone compound

Country Status (1)

Country Link
CN (1) CN109096082B (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108276260A (en) * 2018-04-09 2018-07-13 南京林业大学 A kind of preparation method and products thereof of novel fluoro cyclopentenone

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108276260A (en) * 2018-04-09 2018-07-13 南京林业大学 A kind of preparation method and products thereof of novel fluoro cyclopentenone

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BEATRICE JACQUES等: "Synthesis, Characterization, and Catalytic Activity of Alcohol-Functionalized NHC Gold(I/III) Complexes", 《ORGANOMETALLICS》 *
XIANXIAO CHEN等: "Gold(I)-Catalyzed Tandem Cycloisomerization and Fluorination of 1,3(4)-Enyne Esters with NFSI: One-Pot Assembly of 5-Fluoro-Cyclopentenones", 《ADV. SYNTH. CATAL.》 *
XU ZHOU等: "fficient catalytic enantioselective Nazarov cyclizations of divinyl ketoesters", 《ORGANIC CHEMISTRY FRONTIERS》 *

Also Published As

Publication number Publication date
CN109096082B (en) 2021-04-27

Similar Documents

Publication Publication Date Title
Honma et al. Enantioselective intramolecular cyclopropanation of α-diazo-β-keto sulfones: asymmetric synthesis of bicyclo [4.1. 0] heptanes and tricyclo [4.4. 0.0] decenes
CN106902880A (en) Application of the mercaptopyrimidine univalent copper complex of 4,6 dimethyl 2 in catalysis ketone or aldehyde hydrogen transfer reaction prepare alcohol
Han et al. Photoredox-catalyzed perfluoroalkylation of aminoquinolines with hypervalent iodine (III) reagents that contain perfluoroalkanoate
CN109096067A (en) A kind of method of the alpha-brominated cyclopentenone of synthesizing new
CN110128320A (en) A kind of preparation method of 5- chloro-3-hydroxyl -3- fluoroalkyl-indole-2-ketone compound
CN108358868B (en) Preparation method of 2-substituted benzothiazole compound
JP4109458B2 (en) Fullerene derivatives and metal complexes
CN109096082A (en) A method of synthesis alpha-iodine is for cyclopentene ketone compounds
Manzotti et al. Improved synthesis of prostanoids on a non-cross-linked polystyrene soluble support
CN110294730A (en) A kind of difluoromethyl vulcanization flavone compound and preparation method thereof
CN113548965B (en) Preparation method of 1,4 eneyne compound
Saper et al. Synthesis of chiral heterobimetallic tris (phosphinoamide) Zr/Co complexes
CN109535120A (en) The preparation method of 7- substitution -3,4,4,7- tetrahydro cyclobutane and cumarin -5- ketone
CN110256314B (en) Preparation method of beta-aryl ketone compound and product thereof
Ferber et al. Introduction of a planar chirality onto steroid substrates: synthesis of (S) and (R)-2′-formylcymantrenyl-17α-ethynylestradiols using (S) and (R)-1-formyl-2-iodo-cymantrenes
US5599963A (en) Catalysts for production of β-hydroxy carbonyl compounds
CN107641080A (en) A kind of dihydronaphthalene ketones derivant containing spirane structure and preparation method thereof
CN111153923A (en) Acetylenic ketone derivative and preparation method and application thereof
Potter et al. Iron-mediated synthesis of homochiral 4-methylcyclohexenone derivatives from p-menthoxytoluene
CN108558622B (en) Preparation method of novel 5-allyl cyclopentenone and product thereof
CN113845481B (en) Synthesis method of 4, 4-dimethyl-4, 5-dihydropyridazin-3-one
CN110117270B (en) Preparation method of 3- (thiophene-2-yl) cyclohexanone framework compound
CN111454184B (en) Compound and preparation method thereof, medical intermediate and application thereof
CN110015981B (en) Synthesis method of (2-iodine-2-aryl) ethyl aryl ether derivative
JPH0967312A (en) Asymmetric cyclopropane formation reaction

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant